Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Efficacy of Bacillus Subtilis ATCC 122264 on Intestinal Gas Symptoms and Quality of Life in Participants With Functional Bloating: a Randomized, Double-blind, Placebo-controlled, 2-arm Parallel Study

NCT06308146 is registered in ClinicalTrials.gov with Kerry Group P.L.C as lead sponsor.

NCT NCT06308146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06308146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Efficacy of Bacillus Subtilis ATCC 122264 on Intestinal Gas Symptoms and Quality of Life in Participants With Functional Bloating: a Randomized, Double-blind, Placebo-controlled, 2-arm Parallel Study
Lead sponsor
Kerry Group P.L.C
Phase
Not applicable
Overall status
Completed
Start date
April 21, 2022
Completion date
October 11, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

functional bloating